Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 17 Sep 21 425 Business combination disclosure
- 9 Sep 21 425 Business combination disclosure
- 27 Aug 21 425 Business combination disclosure
- 27 Aug 21 EFFECT Notice of effectiveness
- 26 Aug 21 424B3 Prospectus supplement
- 23 Aug 21 425 Business combination disclosure
- 23 Aug 21 425 Business combination disclosure
- 19 Aug 21 425 Business combination disclosure
- 17 Aug 21 F-4/A Registration of securities (foreign) (amended)
-
30 Jul 21 F-4/A Registration of securities (foreign) (amended)
- 21 Jun 21 F-4 Registration of securities (foreign)
PROC similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement No. 333-257222 on Amendment No. 1 to Form F-4 of our report dated June 21, 2021, relating to the financial statements of Crynssen Pharma Group Limited. We also consent to the reference to us under the heading "Experts" in such Registration Statement.
Bogota, Colombia
July 30, 2021